Mission Creek Capital Partners Inc. Acquires 13,457 Shares of Tempus AI, Inc. $TEM

Key Points

• Mission Creek Capital Partners Inc. increased its holdings in Tempus AI by 28.2%, acquiring an additional 13,457 shares to bring its total to 61,212 shares valued at approximately $2.95 million.
• Tempus AI earned a consensus rating of "Moderate Buy" from equities analysts, with a target price forecast of $67.64 and several firms upgrading their price objectives.
• CEO Eric P. Lefkofsky recently sold 250,000 shares from his stake, totaling over $17.5 million, resulting in a 2.60% decrease in his ownership position.

Mission Creek Capital Partners Inc. boosted its stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 28.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,212 shares of the company's stock after purchasing an additional 13,457 shares during the period. Mission Creek Capital Partners Inc.'s holdings in Tempus AI were worth $2,953,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Cherry Tree Wealth Management LLC purchased a new position in shares of Tempus AI during the 1st quarter worth $31,000. University of Texas Texas AM Investment Management Co. purchased a new position in shares of Tempus AI during the 1st quarter worth $33,000. Bartlett & CO. Wealth Management LLC boosted its stake in shares of Tempus AI by 100.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after acquiring an additional 400 shares during the last quarter. Nemes Rush Group LLC purchased a new position in shares of Tempus AI during the 1st quarter worth $39,000. Finally, Continuum Advisory LLC purchased a new position in shares of Tempus AI during the 1st quarter worth $39,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Tempus AI Price Performance

Shares of TEM traded up $2.20 during trading hours on Friday, reaching $75.86. 7,646,161 shares of the stock traded hands, compared to its average volume of 11,999,090. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $91.45. The company's 50-day moving average price is $64.31 and its two-hundred day moving average price is $59.44. The company has a market cap of $13.18 billion, a P/E ratio of -63.75 and a beta of 4.98.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. Tempus AI's revenue for the quarter was up 89.5% compared to the same quarter last year. During the same period in the previous year, the firm posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. On average, analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

TEM has been the topic of several analyst reports. Bank of America lifted their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC reiterated a "buy" rating and set a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. BTIG Research lifted their price target on shares of Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research note on Wednesday, August 20th. Guggenheim lifted their price target on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Finally, Morgan Stanley lifted their price target on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 12th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $67.64.

Insider Buying and Selling

In other Tempus AI news, CFO James William Rogers sold 7,528 shares of Tempus AI stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the sale, the chief financial officer directly owned 138,473 shares in the company, valued at approximately $10,337,009.45. The trade was a 5.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Andrew Polovin sold 5,398 shares of Tempus AI stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $402,960.70. Following the completion of the sale, the executive vice president owned 132,056 shares in the company, valued at approximately $9,857,980.40. This represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,108,951 shares of company stock worth $77,660,938 in the last 90 days. 26.27% of the stock is owned by company insiders.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.